@mattpappas.bsky.social We estimated just one of the downstream harms of broad-spectrum antibiotics. But I hope this approach--trying to rigorously estimate harms for therapies that don't have RCTs, rather than taking associations at face value--can help us be smarter about lots of treatments we use in the hospital. (8/9)